| New WHO classification of pituitary adenomas (4th edition): assessment of pituitary transcription factors and the prognostic histological factors |
13 |
| The 2017 WHO classification of pituitary adenoma: overview and comments |
12 |
| The emerging clinical potential of circulating extracellular vesicles for non-invasive glioma diagnosis and disease monitoring |
8 |
| Glioblastoma in neurofibromatosis 1 patients without IDH BRAF V600E, and TERT promoter mutations |
8 |
| Paediatric diffuse leptomeningeal tumor with glial and neuronal differentiation harbouring chromosome 1p/19q co-deletion and H3.3 K27M mutation: unusual molecular profile and its therapeutic implications |
7 |
| Novel concept of the border niche: glioblastoma cells use oligodendrocytes progenitor cells (GAOs) and microglia to acquire stem cell-like features |
7 |
| Overview of DNA methylation in adult diffuse gliomas |
7 |
| A long-term survivor of pediatric midline glioma with H3F3A K27M and BRAF V600E double mutations |
5 |
| Anaplastic changes of diffuse leptomeningeal glioneuronal tumor with polar spongioblastoma pattern |
5 |
| Histopathological features to define atypical meningioma: What does really matter for prognosis? |
5 |
| Immunohistochemical ATRX expression is not a surrogate for 1p19q codeletion |
5 |
| Clinical significance of the 2016 WHO classification in Japanese patients with gliomas |
5 |
| Molecular genetics and therapeutic targets of pediatric low-grade gliomas |
5 |
| Identification of a novel KLC1-ROS1 fusion in a case of pediatric low-grade localized glioma |
4 |
| Radiological characteristics based on isocitrate dehydrogenase mutations and 1p/19q codeletion in grade II and III gliomas |
4 |
| Welcoming the new WHO classification of pituitary tumors 2017: revolution in TTF-1-positive posterior pituitary tumors |
4 |
| MN1 rearrangement in astroblastoma: study of eight cases and review of literature |
4 |
| Two cases of primary supratentorial intracranial rhabdomyosarcoma with DICER1 mutation which may belong to a spindle cell sarcoma with rhabdomyosarcoma-like feature, DICER1 mutant |
4 |
| First autopsy analysis of the efficacy of intra-operative additional photodynamic therapy for patients with glioblastoma |
3 |
| Review of ependymomas: assessment of consensus in pathological diagnosis and correlations with genetic profiles and outcome |
3 |
| Practical procedures for the integrated diagnosis of astrocytic and oligodendroglial tumors |
3 |
| Pathologic and molecular aspects of anaplasia in circumscribed gliomas and glioneuronal tumors |
3 |
| A rapidly fatal intracranial anaplastic hemangiopericytoma with de-novo dedifferentiation: emphasis on diagnostic recognition, molecular confirmation and discussion on treatment dilemma |
2 |
| Immunohistochemical detection of ALK protein identifies APC mutated medulloblastoma and differentiates the WNT-activated medulloblastoma from other types of posterior fossa childhood tumors |
2 |
| A surgical strategy for lower grade gliomas using intraoperative molecular diagnosis |
2 |
| Rapid detection of mutation in isocitrate dehydrogenase 1 and 2 genes using mass spectrometry |
2 |
| Clinicopathological characteristics of circumscribed high-grade astrocytomas with an unusual combination of BRAF V600E, ATRX, and CDKN2A/B alternations |
2 |
| High-grade glioneuronal tumor with an ARHGEF2-NTRK1 fusion gene |
2 |
| Clinical, histopathological, and molecular analyses of IDH-wild-type WHO grade II-III gliomas to establish genetic predictors of poor prognosis |
2 |
| Anaplastic pleomorphic xanthoastrocytoma associated with an H3G34 mutation: a case report with review of literature |
2 |
| NRAS(Q61K) mutated diffuse leptomeningeal melanomatosis in an adult patient with a brief review of the so-called forme fruste of neurocutaneous melanosis |
2 |
| Stromal cells of hemangioblastomas exhibit mesenchymal stem cell-derived vascular progenitor cell properties |
1 |
| Clinicopathological evaluation of PD-L1 expression and cytotoxic T-lymphocyte infiltrates across intracranial molecular subgroups of ependymomas: are these tumors potential candidates for immune check-point blockade? |
1 |
| Impact of PCR-based molecular analysis in daily diagnosis for the patient with gliomas |
1 |
| Reclassification of 400 consecutive glioma cases based on the revised 2016WHO classification |
1 |
| A novel high-sensitivity assay to detect a small fraction of mutant IDH1 using droplet digital PCR |
1 |
| Pilomyxoid astrocytomas: a short review |
1 |
| Next-generation whole exome sequencing of glioblastoma with a primitive neuronal component |
1 |
| A case report of adult cerebellar high-grade glioma with H3.1 K27M mutation: a rare example of an H3 K27M mutant cerebellar tumor |
1 |
| Research of differential expression of sIL1RAP in low-grade gliomas between children and adults |
1 |
| The clinicopathological analysis of receptor tyrosine kinases in meningiomas: the expression of VEGFR-2 in meningioma was associated with a higher WHO grade and shorter progression-free survival |
1 |
| Three case reports of radiation-induced glioblastoma after complete remission of acute lymphoblastic leukemia |
0 |
| Enchondromatosis-associated oligodendroglioma: case report and literature review |
0 |
| Tissue microarray analysis for epithelial membrane protein-2 as a novel biomarker for gliomas |
0 |
| Importance and accuracy of intraoperative frozen section diagnosis of the resection margin for effective carmustine wafer implantation |
0 |
| A case of epidural glioblastoma metastasis presenting with a cervical myelopathy, torticollis, and L'hermitte's phenomenon |
0 |
| Molecular profiling of different glioma specimens from an Ollier disease patient suggests a multifocal disease process in the setting of IDH mosaicism |
0 |
